This pro-inflammatory role for miR-34a was confirmed in conventional PB CD1c+ DCs sorted from RA patients in which gene-silencing of miR-34a-inhibited TLR-mediated TNF production (Fig. 4h). The gene discussed is TNF; the disease is rheumatoid arthritis.